Reprogramming Towards Pancreatic ß-Cells

Kevin Docherty

Research output: Chapter in Book/Report/Conference proceedingChapter

3 Citations (Scopus)

Abstract

Reprogramming towards ß-cells is described here in the context of novel cell-based therapies for the treatment of type 1 diabetes (T1D) and potentially type 2 diabetes (T2D). The overall aim is to reverse the decline (T2D) or total absence (T1D) of ß-cells as seen in these diseases. Strategies adopted are based on the huge increase in understanding of the developmental biology of the mouse pancreas that has taken place during the past 20 years or so. It is envisaged that the generation of patient-specific iPS cells may prove valuable in understanding the relative contribution of ß-cells and other tissues to the causes of the disease. Closely related tissues such as liver and other cells of the pancreas have been shown to exhibit certain plasticity in culture and this has been exploited to facilitate reprogramming using a small number of pancreatic transcription factors, including Pdx1, Ngn3, NeuroD1 and MafA.
Original languageEnglish
Title of host publicationNuclear Reprogramming and Stem Cells
EditorsJustin Ainscough, Shinya Yamanaka, Takashi Tada
PublisherHumana Press
Pages177-191
Number of pages15
ISBN (Electronic)9781617792250
ISBN (Print)9781617792243
DOIs
Publication statusPublished - 2012

Publication series

NameStem Cell Biology and Regenerative Medicine
PublisherHumana Press

Fingerprint

Type 1 Diabetes Mellitus
Type 2 Diabetes Mellitus
Pancreas
Developmental Biology
Cell- and Tissue-Based Therapy
Transcription Factors
Liver
Therapeutics
Cellular Reprogramming

Cite this

Docherty, K. (2012). Reprogramming Towards Pancreatic ß-Cells. In J. Ainscough, S. Yamanaka, & T. Tada (Eds.), Nuclear Reprogramming and Stem Cells (pp. 177-191). (Stem Cell Biology and Regenerative Medicine). Humana Press. https://doi.org/10.1007/978-1-61779-225-0_14

Reprogramming Towards Pancreatic ß-Cells. / Docherty, Kevin.

Nuclear Reprogramming and Stem Cells. ed. / Justin Ainscough; Shinya Yamanaka; Takashi Tada. Humana Press, 2012. p. 177-191 (Stem Cell Biology and Regenerative Medicine).

Research output: Chapter in Book/Report/Conference proceedingChapter

Docherty, K 2012, Reprogramming Towards Pancreatic ß-Cells. in J Ainscough, S Yamanaka & T Tada (eds), Nuclear Reprogramming and Stem Cells. Stem Cell Biology and Regenerative Medicine, Humana Press, pp. 177-191. https://doi.org/10.1007/978-1-61779-225-0_14
Docherty K. Reprogramming Towards Pancreatic ß-Cells. In Ainscough J, Yamanaka S, Tada T, editors, Nuclear Reprogramming and Stem Cells. Humana Press. 2012. p. 177-191. (Stem Cell Biology and Regenerative Medicine). https://doi.org/10.1007/978-1-61779-225-0_14
Docherty, Kevin. / Reprogramming Towards Pancreatic ß-Cells. Nuclear Reprogramming and Stem Cells. editor / Justin Ainscough ; Shinya Yamanaka ; Takashi Tada. Humana Press, 2012. pp. 177-191 (Stem Cell Biology and Regenerative Medicine).
@inbook{1164fff0d32a49ec80c86b3182639be2,
title = "Reprogramming Towards Pancreatic {\ss}-Cells",
abstract = "Reprogramming towards {\ss}-cells is described here in the context of novel cell-based therapies for the treatment of type 1 diabetes (T1D) and potentially type 2 diabetes (T2D). The overall aim is to reverse the decline (T2D) or total absence (T1D) of {\ss}-cells as seen in these diseases. Strategies adopted are based on the huge increase in understanding of the developmental biology of the mouse pancreas that has taken place during the past 20 years or so. It is envisaged that the generation of patient-specific iPS cells may prove valuable in understanding the relative contribution of {\ss}-cells and other tissues to the causes of the disease. Closely related tissues such as liver and other cells of the pancreas have been shown to exhibit certain plasticity in culture and this has been exploited to facilitate reprogramming using a small number of pancreatic transcription factors, including Pdx1, Ngn3, NeuroD1 and MafA.",
author = "Kevin Docherty",
year = "2012",
doi = "10.1007/978-1-61779-225-0_14",
language = "English",
isbn = "9781617792243",
series = "Stem Cell Biology and Regenerative Medicine",
publisher = "Humana Press",
pages = "177--191",
editor = "Justin Ainscough and Shinya Yamanaka and Takashi Tada",
booktitle = "Nuclear Reprogramming and Stem Cells",

}

TY - CHAP

T1 - Reprogramming Towards Pancreatic ß-Cells

AU - Docherty, Kevin

PY - 2012

Y1 - 2012

N2 - Reprogramming towards ß-cells is described here in the context of novel cell-based therapies for the treatment of type 1 diabetes (T1D) and potentially type 2 diabetes (T2D). The overall aim is to reverse the decline (T2D) or total absence (T1D) of ß-cells as seen in these diseases. Strategies adopted are based on the huge increase in understanding of the developmental biology of the mouse pancreas that has taken place during the past 20 years or so. It is envisaged that the generation of patient-specific iPS cells may prove valuable in understanding the relative contribution of ß-cells and other tissues to the causes of the disease. Closely related tissues such as liver and other cells of the pancreas have been shown to exhibit certain plasticity in culture and this has been exploited to facilitate reprogramming using a small number of pancreatic transcription factors, including Pdx1, Ngn3, NeuroD1 and MafA.

AB - Reprogramming towards ß-cells is described here in the context of novel cell-based therapies for the treatment of type 1 diabetes (T1D) and potentially type 2 diabetes (T2D). The overall aim is to reverse the decline (T2D) or total absence (T1D) of ß-cells as seen in these diseases. Strategies adopted are based on the huge increase in understanding of the developmental biology of the mouse pancreas that has taken place during the past 20 years or so. It is envisaged that the generation of patient-specific iPS cells may prove valuable in understanding the relative contribution of ß-cells and other tissues to the causes of the disease. Closely related tissues such as liver and other cells of the pancreas have been shown to exhibit certain plasticity in culture and this has been exploited to facilitate reprogramming using a small number of pancreatic transcription factors, including Pdx1, Ngn3, NeuroD1 and MafA.

U2 - 10.1007/978-1-61779-225-0_14

DO - 10.1007/978-1-61779-225-0_14

M3 - Chapter

SN - 9781617792243

T3 - Stem Cell Biology and Regenerative Medicine

SP - 177

EP - 191

BT - Nuclear Reprogramming and Stem Cells

A2 - Ainscough, Justin

A2 - Yamanaka, Shinya

A2 - Tada, Takashi

PB - Humana Press

ER -